Diagnostic Utility of AxSYM Anti-Cyclic Citrullinated Peptide Antibody Assay

被引:5
|
作者
Kim, Kyung-Eun [1 ]
Kim, Kyeong-Hee [1 ]
Woo, Kwang-Sook [1 ]
Han, Jin-Yeong [1 ]
Kim, Jeong-Man [1 ]
Lee, Sung Won [2 ]
Chung, Won Tae [2 ]
机构
[1] Dong A Univ, Dept Lab Med, Coll Med, Pusan 602103, South Korea
[2] Dong A Univ, Dept Internal Med, Coll Med, Pusan 602103, South Korea
来源
KOREAN JOURNAL OF LABORATORY MEDICINE | 2008年 / 28卷 / 06期
关键词
Anti-cyclic citrullinated peptide antibody; Rheumatoid factor; Rheumatoid arthritis; AxSYM immunoassay;
D O I
10.3343/kjlm.2008.28.6.457
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background : The presence of rheumatoid factor (RF) is one of the classification criteria of the American College of Rheumatology (ACR) for rheumatoid arthritis (RA), but it has a limitation of low specificity. We compared the diagnostic utility of anti-cyclic citrullinated peptide (CCP) antibodies analyzed by an automated immunoassay system with that measured by a 96 well plate ELISA method. Methods : The RF and anti-CCIP antibodies were determined in 172 serum samples: 52 RA patients, 73 disease controls (systemic lupus, Sjogren's syndrome, palindromic rheumatism), and 47 healthy controls. Anti-CCP antibodies were measured by DIASTAT 96 well plate ELISA method (Axis-Shield Diagnostics, UK) and AxSYM automated microparticle enzyme immunoassay system (Abbott Laboratories, USA). RF was assayed by latex immunoturbidimetry (Toshiba 200 FR, Japan). The diagnostic performances of these tests were compared using a ROC curve analysis, and linearity and precision analysis of AxSYM anti-CCP was carried out. Results : The sensitivities of RF, DIASTAT anti-CCP, and AxSYM anti-CCP were 78.8%, 84.6%, and 82.7%, respectively and the specificities were 72.5%, 88.3%, and 88.3%, respectively. On ROC curve analysis, the area under the curve was 0.924 for AxSYM anti-CCIP, 0,886 for DIASTAT anti-CCP, and 0.847 for RF AxSYM anti-CCP showed a good linearity, and within-run and total-run precision. Conclusions : Diagnostic performance of automated AxSYM anti-CCP assay was comparable to that of DIASTAT 96 well plate ELISA method. AxSYM anti-CCP assay has an advantage of random access capability and will be useful in laboratories with low sample number and/or with a need of rapid turnaround time. (Korean J Lab Med 2008;28:457-64)
引用
收藏
页码:457 / 464
页数:8
相关论文
共 50 条
  • [41] Diagnostic value of anti-cyclic citrullinated peptide antibody for rheumatoid arthritis in a Chinese population: a meta-analysis
    Gao, Fei
    Ren, Lei
    Zhang, Cai-Qin
    Mu, Feng-Yun
    You, Yan-Qiu
    Liu, Yan-Hong
    [J]. RHEUMATOLOGY INTERNATIONAL, 2012, 32 (10) : 3201 - 3218
  • [42] Meta-analysis: Diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis
    Nishimura, Kunihiro
    Sugiyama, Daisuke
    Kogata, Yoshinori
    Tsuji, Goh
    Nakazawa, Takashi
    Kawano, Seiji
    Saigo, Katsuyasu
    Morinobu, Akio
    Koshiba, Masahiro
    Kuntz, Karen M.
    Kamae, Isao
    Kumagai, Shunichi
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (11) : 797 - 808
  • [43] Diagnostic value of anti-cyclic citrullinated peptide antibody for rheumatoid arthritis in a Chinese population: a meta-analysis
    Fei Gao
    Lei Ren
    Cai-Qin Zhang
    Feng-Yun Mu
    Yan-Qiu You
    Yan-Hong Liu
    [J]. Rheumatology International, 2012, 32 : 3201 - 3218
  • [44] Anti-cyclic citrullinated peptide antibodies in scleroderma patients
    M. Polimeni
    D. Feniman
    T. S. Skare
    Renato M. Nisihara
    [J]. Clinical Rheumatology, 2012, 31 : 877 - 880
  • [45] ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH SARCOIDOSIS
    Kobak, S.
    Yilmaz, H.
    Sever, F.
    Duran, A.
    Sen, N.
    [J]. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2014, 31 (03) : 206 - 210
  • [46] Anti-Cyclic Citrullinated Peptide Antibodies in Patients with Sarcoidosis
    Kobak, Senol
    Yilmaz, Hatice
    Sever, Fidan
    Duran, Arzu
    Sen, Nazime
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S93 - S93
  • [47] Anti-cyclic citrullinated peptide antibodies in scleroderma patients
    Polimeni, M.
    Feniman, D.
    Skare, T. S.
    Nisihara, Renato M.
    [J]. CLINICAL RHEUMATOLOGY, 2012, 31 (05) : 877 - 880
  • [48] Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis
    Abdel Fattah N.S.
    Hassan H.E.
    Galal Z.A.
    El Okda E.S.E.
    [J]. BMC Research Notes, 2 (1)
  • [49] Anti-cyclic citrullinated peptide antibody in early rheumatoid arthritis: comment on the editorial by Scott
    van Venrooij, WJ
    van de Putte, LBA
    van den Hogen, FHJ
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (03): : 857 - 857
  • [50] The Influence of Traditional Herbal Medicine (Kampo) on Anti-cyclic Citrullinated Peptide Antibody Levels
    Kogure, Toshiaki
    Oku, Yuko
    Kishi, Daijiro
    Ito, Tomoyuki
    Tatsumi, Takeshi
    [J]. CLINICAL MEDICINE INSIGHTS-ARTHRITIS AND MUSCULOSKELETAL DISORDERS, 2009, 2 : 23 - 28